↓ Skip to main content

Skipping the co-expression problem: the new 2A "CHYSEL" technology

Overview of attention for article published in Genetic Vaccines and Therapy, September 2004
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (90th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (60th percentile)

Mentioned by

twitter
1 X user
patent
4 patents

Citations

dimensions_citation
97 Dimensions

Readers on

mendeley
255 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Skipping the co-expression problem: the new 2A "CHYSEL" technology
Published in
Genetic Vaccines and Therapy, September 2004
DOI 10.1186/1479-0556-2-13
Pubmed ID
Authors

Pablo de Felipe

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 255 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 5 2%
Australia 2 <1%
United Kingdom 2 <1%
Malaysia 1 <1%
Canada 1 <1%
Portugal 1 <1%
Japan 1 <1%
Belgium 1 <1%
Unknown 241 95%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 69 27%
Researcher 64 25%
Student > Master 38 15%
Student > Bachelor 18 7%
Professor > Associate Professor 12 5%
Other 30 12%
Unknown 24 9%
Readers by discipline Count As %
Agricultural and Biological Sciences 132 52%
Biochemistry, Genetics and Molecular Biology 51 20%
Medicine and Dentistry 13 5%
Immunology and Microbiology 6 2%
Neuroscience 5 2%
Other 20 8%
Unknown 28 11%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 10. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 June 2023.
All research outputs
#3,621,892
of 25,373,627 outputs
Outputs from Genetic Vaccines and Therapy
#4
of 45 outputs
Outputs of similar age
#6,590
of 72,719 outputs
Outputs of similar age from Genetic Vaccines and Therapy
#2
of 5 outputs
Altmetric has tracked 25,373,627 research outputs across all sources so far. Compared to these this one has done well and is in the 85th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 45 research outputs from this source. They receive a mean Attention Score of 4.6. This one scored the same or higher as 41 of them.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 72,719 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 90% of its contemporaries.
We're also able to compare this research output to 5 others from the same source and published within six weeks on either side of this one. This one has scored higher than 3 of them.